Testosterone and Prostate: Myths and Facts
Testosterone and prostate disease are related, but the common statement “testosterone causes prostate cancer” is too simplistic. Testosterone supports normal prostate biology, and prostate cancer can be hormone-sensitive, yet current evidence does not show that appropriately prescribed testosterone replacement automatically creates prostate cancer in men without it. The safe approach is neither fear nor casual prescribing: confirm genuine hypogonadism, assess prostate risk when appropriate, obtain baseline PSA or examination when indicated, and investigate a significant PSA change during treatment.
Myth vs fact: testosterone and the prostate
| Common belief | What the evidence-based view is |
|---|---|
| “TRT always causes prostate cancer.” | Not supported. Appropriate TRT has not been shown to simply create prostate cancer in every treated man. |
| “If PSA rises, TRT must be the cause.” | A PSA rise needs evaluation. Infection, benign enlargement, cancer and normal biological variation are among possible explanations. |
| “Men with any prostate history can never receive testosterone.” | Too absolute. Some carefully selected men after prostate cancer treatment may be considered by specialists, but evidence is limited and selection is important. |
| “A normal PSA means zero prostate cancer risk.” | False. PSA is useful but not a perfect rule-out test; interpretation depends on age, trend, examination and risk factors. |
| “TRT is a treatment for prostate symptoms.” | No. TRT treats confirmed androgen deficiency, not BPH or urinary obstruction. |
Why this topic has been controversial
Androgen deprivation is a major treatment for advanced prostate cancer, so it is logical to ask whether adding testosterone must have the opposite effect. Prostate biology is more complex than a simple linear “more testosterone = more cancer” model. Modern guidelines therefore focus on risk assessment, shared decision-making and monitoring rather than a universal ban in every possible prostate scenario.
Does TRT increase PSA?
A small PSA change can occur after restoring testosterone in some hypogonadal men, particularly when baseline testosterone is very low. A large or persistent rise should not be dismissed as “just TRT”. It should trigger clinical review and, when appropriate, urological evaluation.
TRT and benign prostate enlargement
Benign prostatic hyperplasia (BPH) and low testosterone are both common with ageing, so they often coexist. TRT is not a treatment for BPH. Before starting therapy, men with significant urinary symptoms should be evaluated for prostate size, urinary retention risk and other causes of lower urinary tract symptoms.
- Weak stream, straining or incomplete emptying deserve assessment.
- Acute inability to pass urine is an emergency.
- Do not stop or start prostate medicines solely because TRT has been prescribed without discussing it with your doctor.
A PSA change is a signal to evaluate, not a diagnosis by itself
PSA can change after testosterone is restored, but the number has to be interpreted in context. A single rise can reflect biological variation, benign enlargement, inflammation or cancer. What matters is confirmation, the absolute value, the rate of change, prostate findings and the man’s baseline risk. Dismissing a substantial rise as “just TRT” is as unhelpful as assuming every rise is cancer.
What about men who had prostate cancer?
This is a specialist decision. The 2026 EAU guideline gives only weak support for testosterone treatment in carefully selected men at low risk of recurrence after prostate-cancer surgery, after at least one year of follow-up with PSA below 0.01 ng/mL and no evidence of recurrence. For men on active surveillance or after non-surgical curative treatment, safety data remain uncertain. This should be a urologist-led shared decision, not self-medication.
- Do not self-start testosterone after prostate cancer treatment.
- Bring operative pathology, radiotherapy records and serial PSA values to the consultation.
- The decision depends on cancer risk category, treatment, time since treatment, PSA behaviour, symptoms and competing health risks.
What prostate checks are done before and during TRT?
There is no single identical pathway for every age. The clinician considers age, family history, baseline PSA, prostate symptoms and the reason for TRT.
- PSA when appropriate after informed discussion.
- Digital rectal examination when clinically indicated.
- Review of urinary symptoms.
- Repeat PSA after starting treatment according to the agreed monitoring plan.
- Urology referral for concerning PSA kinetics, a suspicious examination or significant urinary problems.
When to see a urologist promptly
- Blood in urine.
- Inability to pass urine.
- Rapidly worsening urinary obstruction.
- A newly abnormal PSA or significant PSA rise.
- Bone pain, unexplained weight loss or systemic symptoms in a man with prostate cancer history.
What to bring for a prostate/TRT review
Bring these if available:
- Previous PSA reports with dates, not only the latest value.
- Prostate biopsy/MRI/pathology reports if ever done.
- Prostate cancer surgery or radiotherapy records if relevant.
- Current testosterone reports and TRT prescription.
- USG KUB/PVR or uroflowmetry if urinary symptoms were evaluated.
- Family history of prostate cancer and current urinary medicines.
FAQs
Does testosterone replacement cause prostate cancer?
Current evidence does not support saying that correctly prescribed TRT automatically causes prostate cancer. Men still need age- and risk-appropriate prostate assessment.
Can TRT make PSA rise?
PSA can change after testosterone restoration. A significant or persistent rise should be evaluated rather than ignored.
Can I take TRT if I have BPH?
BPH does not automatically exclude TRT, but significant urinary symptoms should be assessed and monitored.
Can a prostate cancer survivor ever take testosterone?
Some carefully selected men may be considered after specialist review, but evidence is not definitive and the decision requires detailed counselling and PSA follow-up.
Do I need PSA before TRT if I am young?
The need depends on age and risk. PSA is not automatically required in every young man, but prostate history and risk factors should be reviewed.
Should TRT be stopped if PSA changes?
Do not make the decision from one number alone. Confirm the result and seek urological evaluation when the rise is clinically significant.
Related reading
- Testosterone Replacement Therapy Explained
- Risks of Testosterone Therapy
- Low Testosterone in Men: Symptoms and Treatment
- PSA Test Explained
- Enlarged Prostate Symptoms, Causes and Treatment
- Urologist in Latur
References
- European Association of Urology. Guidelines on Sexual and Reproductive Health (2026) https://uroweb.org/guidelines/sexual-and-reproductive-health
- Endocrine Society. Testosterone Therapy for Hypogonadism Guideline Resources https://www.endocrine.org/clinical-practice-guidelines/testosterone-therapy
- American Urological Association. Evaluation and Management of Testosterone Deficiency https://www.auanet.org/guidelines-and-quality/guidelines/testosterone-deficiency-guideline